Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 7 Jun 23 424B4 Prospectus supplement with pricing info
- 7 Jun 23 EFFECT Notice of effectiveness
-
6 Jun 23 S-1/A IPO registration (amended)
- 5 Jun 23 S-1/A IPO registration (amended)
- 19 May 23 S-1 IPO registration
RNAZ similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Amendment No.2 to Form S-1, of our report dated March 31, 2023, which includes an explanatory paragraph relating to Transcode Therapeutics, Inc.’s ability to continue as a going concern, relating to the financial statements of Transcode Therapeutics, Inc., which is incorporated by reference in that Prospectus. We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC
East Brunswick, New Jersey
June 6, 2023